Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Buy GenoLogics

NEW YORK (GenomeWeb) – Illumina has signed an agreement to acquire GenoLogics Life Sciences Software, a developer of laboratory information management systems for life science organizations, for an undisclosed amount.

The acquisition is expected to close by the end of August. Following the close of purchase, GenoLogics will become part of Illumina's enterprise informatics business and will be under the purview of Sanjay Chikarmane, senior vice president and general manager of enterprise informatics.

The company developed and sells the GenoLogics' Clarity LIMS software, a LIM system tailored for the needs of clinical and research laboratories. Clarity LIMS, which is optimized for use with Illumina sequencing instruments, offers improved sample throughput, increased accuracy, and fast turnaround, among other benefits, according to GenoLogics.

Illumina President Francis deSouza said in a statement that the acquisition demonstrates his firm's "commitment to drive the adoption of sequencing in new markets and improve the genomic information workflow."

"Adding GenoLogics' products to Illumina's portfolio is another example of our continued commitment to bring innovative sample-to-answer solutions to research and clinical labs," he said.

"Illumina and GenoLogics have had a longstanding partnership," Michael Ball, GenoLogics' CEO, added, "and this acquisition will enable us to widen our distribution, accelerate our product development, and provide even greater support to the Clarity LIMS community." 

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.